195 related articles for article (PubMed ID: 8796997)
21. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.
Sato H; Seiki M
J Biochem; 1996 Feb; 119(2):209-15. PubMed ID: 8882706
[TBL] [Abstract][Full Text] [Related]
22. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
Gallegos NC; Smales C; Savage FJ; Hembry RM; Boulos PB
Surg Oncol; 1995; 4(2):111-9. PubMed ID: 7551259
[TBL] [Abstract][Full Text] [Related]
23. Purification, identification and characterisation of seprase from bovine serum.
Collins PJ; McMahon G; O'Brien P; O'Connor B
Int J Biochem Cell Biol; 2004 Nov; 36(11):2320-33. PubMed ID: 15313476
[TBL] [Abstract][Full Text] [Related]
24. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma.
Mori Y; Kono K; Matsumoto Y; Fujii H; Yamane T; Mitsumata M; Chen WT
Oncology; 2004; 67(5-6):411-9. PubMed ID: 15713998
[TBL] [Abstract][Full Text] [Related]
25. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2.
Young TN; Rodriguez GC; Rinehart AR; Bast RC; Pizzo SV; Stack MS
Gynecol Oncol; 1996 Jul; 62(1):89-99. PubMed ID: 8690299
[TBL] [Abstract][Full Text] [Related]
26. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
27. MMP-2: expression, activation and inhibition.
Corcoran ML; Hewitt RE; Kleiner DE; Stetler-Stevenson WG
Enzyme Protein; 1996; 49(1-3):7-19. PubMed ID: 8796994
[TBL] [Abstract][Full Text] [Related]
28. Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA: expressed in adrenocortical cancers but not in adenomas.
Kjellman M; Enberg U; Höög A; Larsson C; Holst M; Farnebo LO; Sato H; Bäckdahl M
World J Surg; 1999 Mar; 23(3):237-42. PubMed ID: 9933692
[TBL] [Abstract][Full Text] [Related]
29. Pathological roles of invadopodia in cancer invasion and metastasis.
Yamaguchi H
Eur J Cell Biol; 2012; 91(11-12):902-7. PubMed ID: 22658792
[TBL] [Abstract][Full Text] [Related]
30. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
Sato H; Okada Y; Seiki M
Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
[TBL] [Abstract][Full Text] [Related]
31. Emerging roles for proteinases in cancer.
Noël A; Gilles C; Bajou K; Devy L; Kebers F; Lewalle JM; Maquoi E; Munaut C; Remacle A; Foidart JM
Invasion Metastasis; 1997; 17(5):221-39. PubMed ID: 9876217
[TBL] [Abstract][Full Text] [Related]
32. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
33. Proteases and protease inhibitors in tumor progression.
DeClerck YA; Imren S; Montgomery AM; Mueller BM; Reisfeld RA; Laug WE
Adv Exp Med Biol; 1997; 425():89-97. PubMed ID: 9433492
[TBL] [Abstract][Full Text] [Related]
34. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes.
Gottschall PE; Yu X
J Neurochem; 1995 Apr; 64(4):1513-20. PubMed ID: 7891077
[TBL] [Abstract][Full Text] [Related]
35. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function.
Artym VV; Zhang Y; Seillier-Moiseiwitsch F; Yamada KM; Mueller SC
Cancer Res; 2006 Mar; 66(6):3034-43. PubMed ID: 16540652
[TBL] [Abstract][Full Text] [Related]
36. Proteases and their inhibitors in human brain tumours: a review.
Rooprai HK; McCormick D
Anticancer Res; 1997; 17(6B):4151-62. PubMed ID: 9428349
[TBL] [Abstract][Full Text] [Related]
37. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
[TBL] [Abstract][Full Text] [Related]
38. [Matrix metalloproteinases and cancer cell invasion and metastasis].
Imai K
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1694-700. PubMed ID: 9279101
[No Abstract] [Full Text] [Related]
39. Stromal cell expression of components of matrix-degrading protease systems in human cancer.
Hewitt R; Danø K
Enzyme Protein; 1996; 49(1-3):163-73. PubMed ID: 8797004
[TBL] [Abstract][Full Text] [Related]
40. [Proteolysis directed by the extracellular matrix].
Hornebeck W; Emonard H; Maquart FX; Bellon G
J Soc Biol; 2003; 197(1):25-30. PubMed ID: 12868263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
